Search Results 1911-1920 of 21504 for platelets

  1. A Study to Evaluate the Safety and Effectiveness of TT-00420 in Adults with Advanced Cholangiocarcinoma - Mayo Clinic

    Platelets (plt) ≥ 75 x 10^9 /L;; AST/SGOT and ALT/SGPT ≤ 2.5 x Upper Limit of Normal (ULN) or ≤ 5.0 x ULN if liver metastases are present;; Total bilirubin ...

  2. A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency and Low p16 Expression - Mayo Clinic

    platelet count ≥ 100 x 109/L; Renal function, as follows: Serum creatinine ≤ 1.5 x the ULN or calculated creatinine clearance ≥ 40 mL/min; AST and ALT ...

  3. A Double Blind, Randomized Controlled Study, Evaluating the Safety and Efficacy of RD2 Ver.02 For the Management of Anal Fistulas - Mayo Clinic

    ... Platelets <150.0 x109/L Albuminemia <3.0 g/dL. Patients who do not wish to or cannot comply with study procedures. Patients currently receiving or having ...

  4. 5-strain Probiotic Formulation in Hormone Receptor-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss - Mayo Clinic

    Platelet count ≥ 75,000/mm3; Hemoglobin ≥ 9.0 g/dL; Creatinine ≤ 2 x ULN; SGOT (AST) ≤ 2 x ULN; Albumin ≥ 3 g/dL. Willing and able to provide research ...

  5. A Study to Evaluate Yttrium-90 Therapy for Radiation Lobectomy - Mayo Clinic

    Platelets > 25 K/uL. Patient is willing participate in this study and has signed consent the consent. For Group 2 patients only: Patients planned 90Y dose ...

  6. A Study of Sporadic Angiomyolipomas Growth Kinetics While on Everolimus - Mayo Clinic

    Absolute neutrophil count ≥ 1,500/ microliter (mcL); Hemoglobin ≥10 g/dL; Platelets ≥ 100,000/ mcL; International normalized ratio (INR) ≤ 1.2 X Upper ...

  7. A Study of Using Palbociclib Combined with Standard Adjuvant Endocrine Therapy versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive/ Human Epidermal Growth Factor Receptor 2 Negative Early Breast Cancer - Mayo Clinic

    Platelets ≥ 100,000/ mm3^. Hemoglobin ≥ 10g/dL. Total serum bilirubin ≤ ULN; or total bilirubin ≤ 3.0 × ULN with direct bilirubin within normal range in ...

  8. P1101 in Treating Patients With Myelofibrosis - Mayo Clinic

    Platelet count >= 100,000/mm^3; Absolute neutrophil count (ANC) >= 1000/mm^3; Aspartate transaminase (AST) =< 2.5 x upper limit of normal (ULN); Alanine ...

  9. Phase 1 Study to Evaluate the Safety of ATA188 in Subjects With Progressive and Relapsing-Remitting Multiple Sclerosis - Mayo Clinic

    Hemoglobin < 10 g/dL; platelet < 100×109/L; absolute neutrophil count < 1.5×109/L. Any contraindication to MRI and/or Gd, eg, any object that is reactive to ...

  10. Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III - Mayo Clinic

    Platelet count < 100,000, international normalized ratio (INR) > 1.4, or an elevated prothrombin time (PT) or activated partial thromboplastin time (aPTT).